| Literature DB >> 26085968 |
Charles H Tegeler1, Hossam A Shaltout2, Catherine L Tegeler1, Lee Gerdes3, Sung W Lee3.
Abstract
OBJECTIVE: Explore potential use of a temporal lobe electrical asymmetry score to discriminate between sympathetic and parasympathetic tendencies in autonomic cardiovascular regulation.Entities:
Keywords: Autonomic nervous system; RDoC; heart rate variability; hemispheric asymmetry; neurotechnology; temporal lobe
Mesh:
Year: 2015 PMID: 26085968 PMCID: PMC4467777 DOI: 10.1002/brb3.343
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
Figure 1(A and B) FFT spectral displays, as examples of observed electrical brain activity data from two study participants. Frequency (Hz, central Y axis) is plotted against transformed amplitude (μv, X axis). Data represent one minute of data recorded from the right (T4) and left (T3) temporal montage with eyes closed at the baseline assessment. Red boxes denote the high frequency, 23–36 Hz range analyzed for temporal high-frequency electrical asymmetry. (A) is from a 14-year-old male athlete who enrolled for persisting postconcussion symptoms, primarily headache [note rightward asymmetry in the high frequencies (red box)], while (B) is from a 57-year-old female who reported a variety of symptoms, but enrolled primarily for insomnia [note leftward asymmetry in high frequencies (red box)].
Percentage of subjects using various medications or supplements, listed according to their baseline dominance pattern in temporal high-frequency asymmetry. P values ≤ 0.05 are indicated with an asterisk
| ≥5% Leftward Dominant ( | ≥5% Rightward Dominant ( | ||
|---|---|---|---|
| Beta-Blocker | 13.3 | 10.9 | 0.71 |
| Antidepressant | 22.2 | 14.1 | 0.27 |
| Sedative-hypnotic | 42.2 | 21.9 | 0.02* |
| Other neuropharmacological agent | 17.8 | 12.5 | 0.45 |
| Statin | 13.3 | 7.8 | 0.35 |
| Herb or supplement with known effects on ANS | 35.6 | 32.8 | 0.77 |
| Thyroid medication | 11.1 | 7.8 | 0.56 |
| ACE-I or ARB | 6.7 | 6.3 | 0.93 |
| Stimulant | 6.7 | 6.3 | 0.93 |
| Other hormone | 15.6 | 18.8 | 0.67 |
| Diabetes-related medication | 0 | 3.1 | 0.23 |
| Calcium channel blocker | 4.4 | 7.8 | 0.49 |
Averages for metrics of autonomic cardiovascular regulation for a heterogeneous clinical population (n = 131), for subjects with rightward versus leftward dominance of temporal high frequency electrical activity, using a range of values for defining asymmetry. Metrics analyzed include heart rate, the standard deviation of all normal RR intervals (SDNN), spectral high frequency (HF), and baroreflex sensitivity (BRS). P values ≤0.05 are indicated with an asterisk
| Heart rate (beats/min) | SDNN (ms) | HF (ms2) | BRS (ms/mmHg) | |
|---|---|---|---|---|
| ≥5% asymmetry | ||||
| T3 group average ( | 63.8 | 46.0 | 971.3 | 14.8 |
| T4 group average ( | 72.3 | 39.6 | 620.7 | 13.0 |
| | 0.004* | 0.09 | 0.16 | 0.32 |
| ≥10% asymmetry | ||||
| T3 group average ( | 63.0 | 46.2 | 1098.8 | 14.6 |
| T4 group average ( | 71.5 | 41.3 | 694.0 | 14.2 |
| | 0.01* | 0.27 | 0.18 | 0.86 |
| ≥20% asymmetry | ||||
| T3 group average ( | 64.2 | 46.4 | 1141.9 | 14.3 |
| T4 group average ( | 72.2 | 42.4 | 765.3 | 14.7 |
| | 0.05* | 0.44 | 0.30 | 0.89 |
| ≥30% asymmetry | ||||
| T3 group average ( | 64.6 | 46.7 | 1022.7 | 15.2 |
| T4 group average ( | 71.4 | 41.1 | 718.3 | 14.0 |
| | 0.05* | 0.32 | 0.44 | 0.68 |
| ≥40% asymmetry | ||||
| T3 group average ( | 63.5 | 46.2 | 948.0 | 16.4 |
| T4 group average ( | 69.1 | 37.2 | 473.9 | 10.6 |
| | 0.09 | 0.17 | 0.21 | 0.03* |
| ≥50% asymmetry | ||||
| T3 group average ( | 64.2 | 46.2 | 790.9 | 16.7 |
| T4 group average ( | 67.5 | 35.3 | 435.6 | 10.4 |
| | 0.37 | 0.13 | 0.33 | 0.05* |